GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmiva AB (OSTO:PHARM) » Definitions » Additional Paid-In Capital

Pharmiva AB (OSTO:PHARM) Additional Paid-In Capital : kr106.51 Mil(As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Pharmiva AB Additional Paid-In Capital?


Pharmiva AB's quarterly additional paid-in capital stayed the same from Dec. 2022 (kr106.51 Mil) to Mar. 2023 (kr106.51 Mil) and stayed the same from Mar. 2023 (kr106.51 Mil) to Jun. 2023 (kr106.51 Mil).

Pharmiva AB's annual additional paid-in capital increased from Dec. 2020 (kr57.48 Mil) to Dec. 2021 (kr88.06 Mil) and increased from Dec. 2021 (kr88.06 Mil) to Dec. 2022 (kr106.51 Mil).


Pharmiva AB Additional Paid-In Capital Historical Data

The historical data trend for Pharmiva AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmiva AB Additional Paid-In Capital Chart

Pharmiva AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Additional Paid-In Capital
37.63 57.48 88.06 106.51

Pharmiva AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 88.06 106.55 106.51 106.51 106.51

Pharmiva AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Pharmiva AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Pharmiva AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmiva AB (OSTO:PHARM) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Sankt Lars Väg 45B, Lund, SWE, 222 70
Pharmiva AB is a medical technology company. It develops innovative antibiotic-free medical products in order to improve vaginal health.

Pharmiva AB (OSTO:PHARM) Headlines

No Headlines